TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas

OBJECTIVE: To test if TP53 hot spot mutations (HSMs) confer differential chemotherapy resistance or survival outcomes, the effects of microtubule stabilizers on human ovarian carcinoma cells (OCCs) expressing TP53 HSMs were studied in vitro. Survival outcomes of patients with high grade serous epith...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Gynecol Oncol
Asıl Yazarlar: Seagle, Brandon-Luke L., Yang, Chia-Ping Huang, Eng, Kevin H., Dandapani, Monica, Odunsi-Akanji, Oluwatosin, Goldberg, Gary L., Odunsi, Kunle, Horwitz, Susan Band, Shahabi, Shohreh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5303002/
https://ncbi.nlm.nih.gov/pubmed/25958320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2015.04.039
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller